Moat
8.0/10
Scale, regulated plan operations, Blue plan brands, provider networks, employer and government contracts, claims data, and integrated Carelon services create substantial barriers to entry.
ELVQueued from the May 25, 2026 S&P 500 market-cap snapshot ranks 151-175; reviewed against public company, market-data, and open-source health software sources on 2026-05-31.
Elevance Health
Elevance Health is a U.S. health benefits company offering medical, pharmacy, behavioral, clinical, and care management services through affiliated health plans and Carelon.
Metadata
Where this company sits
- Ticker
- ELV
- Rank snapshot
- ≈ 160
- Sector
- Health Care
- Industry
- Managed Health Care
- Region
- United States
- Index
- S&P 500 · Top 175 by market cap
Metrics
Scoring view
Every metric is paired with a short rationale. The numbers are deliberate, not divine.
Decentralizability
4.0/10
The regulated insurer balance-sheet role is difficult to decentralize, but claims administration, health financing workflows, patient records, and care coordination have credible open and federated substitutes.
Profitability
7.0/10
Elevance remained strongly profitable in 2025, with reported operating revenue near $197.6 billion and net income around $5.7 billion, though managed-care margins are structurally thinner than software or payments businesses.
Price / Earnings
16.7x
CompaniesMarketCap reported Elevance Health's trailing P/E ratio at about 16.7 in May 2026.
Market cap
$85.7B
CompaniesMarketCap reported Elevance Health market capitalization of about $85.71 billion as of May 2026.
Freed-up capital potential
$10.3B
Derived from market cap, moat resistance, decentralizability, and profitability. It is a directional estimate of value capture that could come under pressure if open alternatives compound.
Narrative
Why the company matters
A short editorial overview plus the current thesis on moat strength and decentralization pressure.
Business mix
Elevance Health operates affiliated health plans under brands including Anthem Blue Cross and Blue Shield and Wellpoint, while Carelon houses healthcare services that combine technology, data, pharmacy, behavioral health, and care management capabilities.
The company reported 2025 operating revenue of about $197.6 billion, showing the scale of its premium, product, and services businesses across commercial, Medicare, Medicaid, and care-services markets.
Control points
The moat is rooted less in a single consumer-facing product than in regulated plan administration, Blue Cross and Blue Shield brand territories, employer and government contracts, provider networks, claims data, utilization management, and pharmacy or care-management integration.
Those control points are hard for small entrants to replicate because they require capital, licenses, compliance operations, risk management, actuarial credibility, provider contracting, and claims infrastructure.
Moat reading
Elevance Health has a strong incumbent moat because managed health care rewards scale, regulated execution, claims history, provider network breadth, and trusted employer or government purchasing relationships. Its affiliated Blue plans and Carelon services also create cross-selling and data advantages across insurance, pharmacy, behavioral health, and complex-care workflows.
The moat is not absolute. Public-sector procurement, interoperability mandates, employer cost pressure, and open digital public goods can expose slices of the stack, especially claims administration, eligibility, benefit configuration, patient records, and care coordination.
Decentralization reading
A full replacement for a national regulated insurer is not near-term decentralizable because underwriting, solvency, network contracting, and compliance remain jurisdiction-heavy and capital-intensive. However, pieces of the health-benefits stack can be made more open: benefits administration, claims submission, member identity, care records, referrals, and outcome reporting.
The strongest decentralization path is not a crypto-native health insurer. It is a federated public-interest health financing and care-coordination stack where employers, unions, cooperatives, public agencies, providers, and patients share interoperable rails while retaining local governance and auditability.
Products
Where the moat actually touches users
These pages zoom into the products and services that matter most to each company, the alternatives already nibbling at them, and 2 structured disruption concepts across the current product set.
2 disruption concepts tracked0 documented exceptions
Anthem Blue Cross and Blue Shield
Health benefits and insurance plans
1 conceptAnthem Blue Cross and Blue Shield affiliated plans are Elevance Health's major health-plan brands, offering commercial, Medicare, Medicaid, and related health benefits in multiple U.S. states.
Carelon
Healthcare services, care management, pharmacy, and analytics
1 conceptCarelon is Elevance Health's healthcare services business, combining technology, data, clinical expertise, pharmacy, behavioral health, and complex-care services.
Technology waves
Strategic lenses
These are the repo's explicit bias terms: the technologies expected to keep making incumbents less inevitable over time.
Bitcoin and Lightning as coordination rails
Proof-of-work economics, programmable payment flows, and anti-spam pricing make more digital systems capable of rewarding signal while resisting abuse.
- • Platforms that monetize gatekeeping could face pressure from protocol-native payment and reputation layers.
- • Micropayments can replace some ad-funded or subscription-heavy distribution models.
- • Open systems with credible anti-spam economics deserve a higher decentralizability score than legacy software assumptions suggest.
Paper trail
Visible evidence trail
These sources shaped the scoring and writing. The site is opinionated, but it should not behave like it is improvising facts in a dark room.
Our Companies
Elevance Health · product page
Primary company source for Elevance Health's health-plan brands, Carelon services business, and company positioning.
Reviewed 2026-05-31
Elevance Health 2025 Form 10-K
Elevance Health Investor Relations · annual report
Annual-report source for 2025 operating revenue, profitability, segment context, and business risk profile.
Reviewed 2026-05-31
Elevance Health (ELV) Market Capitalization
CompaniesMarketCap · market data
Market-data source for Elevance Health's May 2026 market capitalization and market-cap history.
Reviewed 2026-05-31
Elevance Health (ELV) P/E Ratio
CompaniesMarketCap · market data
Market-data source for trailing P/E ratio used in valuation scoring.
Reviewed 2026-05-31